A5039583656- Chemotherapy-induced cardiotoxicity and mitigation
- Pituitary Gland Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
- Cancer, Hypoxia, and Metabolism
- Diabetes and associated disorders
- Cerebrovascular and Carotid Artery Diseases
- Chronic Disease Management Strategies
- Cancer Treatment and Pharmacology
- Diabetes Management and Research
- Cardiovascular Health and Disease Prevention
- Mitochondrial Function and Pathology
Endocrinology Research Center
2024
Sechenov University
2023
Background. Type 1 diabetes mellitus (T1DM) is a severe disease associated with reduced life expectancy. Understanding the causes and methods of reducing risks for this cohort highly relevant developing measures to reduce number years lost. Aim. To assess clinical outcomes: frequency diabetic complications, structure mortality among T1DM patients who were examined at dynamic examination in mobile center "Diamobil" Arkhangelsk region 2005 2023. Materials methods. The study was conducted on...
Background: Endothelial dysfunction is recognized as one of the early markers cardiovascular disorders. It supposed to be a potential predictor complications in patients receiving adjuvant and neoadjuvant chemotherapy.
 Aim: To estimate prevalence endothelial solid cancer compared that individuals without any malignancies.
 Materials methods: This observational study included 74 with malignancies, mostly gastrointestinal. Prior polychemotherapy, all were examined for function small...
To evaluate the dynamics of LV global longitudinal strain (GLS) and other EchoCG parameters after high-dose chemotherapy (HDCT) autologous hematopoietic stem cell transplantation (aHSCT).The risk dysfunction in patients HDCT followed by aHSCT has not been sufficiently studied. This study included 74 with hemoblastosis aged 20 to 65 years who had undergone aHSCT. All a history antitumor treatment. assessment GLS measurements troponin T N-terminal pro-brain natriuretic peptide (NT-proBNP) were...